Geiger and colleagues [19] performed a comparison of blood nucleosome cfDNA and other potential stroke biomarkers such as neuron-specific enolase (NSE), S100 protein, and C-reactive protein in ischemic stroke patients. The gene discussed is ENO2; the disease is Stroke.